Medical Devices

August 01, 2014

Buy ($175)

Topics covered: Orthopedics and Cardiovascular Medical Devices, Medical Technology Innovation, Medical Equipment Growth Opportunities, Medical Device Innovation and Consolidation Trends, Efficient Patient Treatment, Bifurcation in Medical Devices, Aging U.S. Population, Affordable Care Act

Companies covered: Tandem Diabetes Care, Inc. (NASDAQ:TNDM), Vision-Sciences, Inc. (NASDAQ:VSCI), The Spectranetics Corporation (NASDAQ:SPNC), Zimmer Holdings, Inc. (NYSE:ZMH), NuVasive, Inc. (NASDAQ:NUVA), Johnson & Johnson (NYSE:JNJ), Baxter International Inc. (NYSE:BAX), Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA), Navidea Biopharmaceuticals, Inc. (NYSEAMERICAN:NAVB), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Medtronic, Inc. (NYSE:MDT), Cytori Therapeutics Inc (NASDAQ:CYTX), Cyberonics, Inc. (NASDAQ:CYBX), Covidien Ltd. (NYSE:COV), DexCom, Inc. (NASDAQ:DXCM), Bio-Techne Corp (NASDAQ:TECH)